Locations:
Search
Hyperthermic intraperitoneal chemotherapy can improve patient outcomes
Leaning into therapies with the strongest evidence
A Q&A with Cleveland Clinic’s board-certified pediatric and adolescent gynecologist
Increasing uptake remains a challenge
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Multidisciplinary teams work together in in-situ scenarios
Uterine transposition cleared the field for radiation therapy
Q&A with new classical hematology program leader
Prescribing eye drops is complicated by unknown risk of fetotoxicity and lack of clinical evidence
Advancements in equipment and technology drive the use of HCL therapy for pregnant women with T1D
ACOG-informed guidance considers mothers and babies
Advertisement
Advertisement